Sabra Health Care REIT, Inc. reported first quarter of 2026 results: EPS $0.16. Guidance reaffirmed.
“Results per diluted common share for the first quarter of 2026 were as follows: • Net Income: $0.16”
Sabra Health Care REIT, Inc. — fact timeline
Source-grounded facts extracted from Sabra Health Care REIT, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Sabra Health Care REIT, Inc. incurred term loan of $500.0 million U.S. dollar term loan with KeyBank National Association as Administrative Agent and the lenders at ratings-based applicable interest margin plus, at the Operating Partnership’s op maturing July 30, 2030.
“The Term Loan Credit Agreement includes a $500.0 million U.S. dollar term loan (the “Term Loan”). The Term Loan Credit Agreement also contains an accordion feature that can increase the total available borrowings to $1.0 billion, subject to terms and conditions. The Term Loan has a maturity date of July 30, 2030. The Term Loan bears interest on the outstanding principal amount at a ratings-based applicable interest margin plus, at the Operating Partnership’s option, either (a) Daily SOFR, (b) Term SOFR or (c) the Base Rate, each as defined in the Term Loan Credit Agreement. The ratings-based applicable interest margin for borrowings will vary based on the Debt Ratings, as defined in the Term Loan Credit Agreement, and will range from 0.800% to 1.600% per annum for SOFR-based borrowings and 0.000% to 0.600% per annum for borrowings at the Base Rate.”
Darrin Smith was appointed as Chief Investment Officer at Sabra Health Care REIT, Inc..
“Darrin Smith, Sabra’s Executive Vice President – Investments, is expected to assume this position effective January 1, 2026.”
Talya Nevo-Hacohen retired as Executive Vice President, Chief Investment Officer and Treasurer at Sabra Health Care REIT, Inc..
“Talya Nevo-Hacohen, the Company’s Executive Vice President, Chief Investment Officer and Treasurer, has decided to retire from Sabra, effective December 31, 2025”
Clifton J. Porter II departed as Director at Sabra Health Care REIT, Inc..
“On November 7, 2024, Clifton J. Porter II notified the Board of Directors of Sabra Health Care REIT, Inc. (the “Company”) of his decision not to stand for reelection to the Company’s Board of Directors at the Company’s 2025 annual meeting of shareholders.”
Sabra Health Care REIT, Inc. updated its the three month period ended March 31, 2024 guidance (reaffirmed).
“On May 8, 2024, Sabra Health Care REIT, Inc. (“Sabra”) issued a press release reporting its results of operations for the three month period ended March 31, 2024.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.